Associate Professor Alexandros Briasoulis

Associate Professor Alexandros Briasoulis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

HF Cardiologist focused on LVADs, Cardiac Transplantation, Pulmonary Hypertension and Amyloidosis. Affiliated with National Kapodistrian University of Athens in Greece and University of Iowa in the USA.

Presentations Articles

Effect of intravenous iron-carbohydrate complexes in patients with heart failure with reduced ejection fraction and iron deficiency: a meta-analysis of randomized controlled trials

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Aspects of comorbidity and heart failure

Access

Effects of treatment response on echocardiographic features among patients with light-chain cardiac amyloidosis

Event: ESC Congress 2023

Topic: Myocardial Disease

Session: Risk stratification in hypertrophic left ventricle

Access

Impact of new allocation system on length of stay following heart transplantation in the US

Event: ESC Congress 2023

Topic: Heart Transplantation

Session: Options for advanced heart failure

Access

Predictors and outcomes of rejection requiring treatment within the first year following heart transplantation

Event: ESC Congress 2023

Topic: Heart Transplantation

Session: Advanced heart failure therapies: transplant and MCS

Access

Impact of age on the utility of CardioMEMs device to guide heart failure therapy: analysis of the National Readmissions Database

Event: ESC Congress 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic heart failure - HFpEF - HFrEF - HFmREF

Access

Pulmonary artery pressure-guided therapy in patients with heart failure using the CardioMEMS device and HF readmissions: analysis of the National Readmissions Database

Event: ESC Congress 2022

Topic: Haemodynamics of Heart Failure

Session: Pathophysiology and mechanisms of heart failure

Access

Characteristics and outcomes of left ventricular assist device recipients transplanted before and after the new donor heart allocation system

Event: ESC Congress 2022

Topic: Heart Transplantation

Session: Chronic heart failure - Left ventricular assist device

Access

Impact of preoperative hemodynamic optimization on right ventricular failure after left ventricular assist device implantation

Event: ESC Congress 2022

Topic: Heart Transplantation

Session: Chronic heart failure - Left ventricular assist device

Access

The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis

Event: ESC Congress 2022

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure - Amyloidosis

Access

Characteristics, predictors and outcomes of early mTOR inhibitor use after heart transplantation: insights from the UNOS database

Event: ESC Congress 2022

Topic: Heart Transplantation

Session: Heart transplantation

Access

ESC 365 is supported by

Explore sponsored resources

Associate Professor Alexandros Briasoulis

Biography

Contributor content

Effect of intravenous iron-carbohydrate complexes in patients with heart failure with reduced ejection fraction and iron deficiency: a meta-analysis of randomized controlled trials

Effects of treatment response on echocardiographic features among patients with light-chain cardiac amyloidosis

Impact of new allocation system on length of stay following heart transplantation in the US

Predictors and outcomes of rejection requiring treatment within the first year following heart transplantation

Impact of age on the utility of CardioMEMs device to guide heart failure therapy: analysis of the National Readmissions Database

Pulmonary artery pressure-guided therapy in patients with heart failure using the CardioMEMS device and HF readmissions: analysis of the National Readmissions Database

Characteristics and outcomes of left ventricular assist device recipients transplanted before and after the new donor heart allocation system

Impact of preoperative hemodynamic optimization on right ventricular failure after left ventricular assist device implantation

The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis

Characteristics, predictors and outcomes of early mTOR inhibitor use after heart transplantation: insights from the UNOS database

ESC 365 is supported by

Associate Professor Alexandros Briasoulis Follow

Biography

Contributor content

Effect of intravenous iron-carbohydrate complexes in patients with heart failure with reduced ejection fraction and iron deficiency: a meta-analysis of randomized controlled trials

Effects of treatment response on echocardiographic features among patients with light-chain cardiac amyloidosis

Impact of new allocation system on length of stay following heart transplantation in the US

Predictors and outcomes of rejection requiring treatment within the first year following heart transplantation

Impact of age on the utility of CardioMEMs device to guide heart failure therapy: analysis of the National Readmissions Database

Pulmonary artery pressure-guided therapy in patients with heart failure using the CardioMEMS device and HF readmissions: analysis of the National Readmissions Database

Characteristics and outcomes of left ventricular assist device recipients transplanted before and after the new donor heart allocation system

Impact of preoperative hemodynamic optimization on right ventricular failure after left ventricular assist device implantation

The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis

Characteristics, predictors and outcomes of early mTOR inhibitor use after heart transplantation: insights from the UNOS database

ESC 365 is supported by

Associate Professor Alexandros Briasoulis